Spdr Sp Pharmaceuticals Etf Performance

XPH Etf  USD 43.73  0.25  0.57%   
The entity has a beta of 0.3, which indicates not very significant fluctuations relative to the market. As returns on the market increase, SPDR SP's returns are expected to increase less than the market. However, during the bear market, the loss of holding SPDR SP is expected to be smaller as well.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SPDR SP Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, SPDR SP is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders. ...more
1
Seven Stocks and Seven Sectors to Watch - TheStreet
10/24/2024
2
Proactive Strategies - Stock Traders Daily
01/02/2025
In Threey Sharp Ratio-0.18
  

SPDR SP Relative Risk vs. Return Landscape

If you would invest  4,607  in SPDR SP Pharmaceuticals on October 23, 2024 and sell it today you would lose (234.00) from holding SPDR SP Pharmaceuticals or give up 5.08% of portfolio value over 90 days. SPDR SP Pharmaceuticals is generating negative expected returns assuming volatility of 1.0743% on return distribution over 90 days investment horizon. In other words, 9% of etfs are less volatile than SPDR, and above 99% of all equities are expected to generate higher returns over the next 90 days.
  Expected Return   
       Risk  
Considering the 90-day investment horizon SPDR SP is expected to under-perform the market. In addition to that, the company is 1.27 times more volatile than its market benchmark. It trades about -0.08 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.05 per unit of volatility.

SPDR SP Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for SPDR SP's investment risk. Standard deviation is the most common way to measure market volatility of etfs, such as SPDR SP Pharmaceuticals, and traders can use it to determine the average amount a SPDR SP's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0755

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsXPH

Estimated Market Risk

 1.07
  actual daily
9
91% of assets are more volatile

Expected Return

 -0.08
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.08
  actual daily
0
Most of other assets perform better
Based on monthly moving average SPDR SP is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of SPDR SP by adding SPDR SP to a well-diversified portfolio.

SPDR SP Fundamentals Growth

SPDR Etf prices reflect investors' perceptions of the future prospects and financial health of SPDR SP, and SPDR SP fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on SPDR Etf performance.

About SPDR SP Performance

By evaluating SPDR SP's fundamental ratios, stakeholders can gain valuable insights into SPDR SP's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if SPDR SP has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if SPDR SP has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
In seeking to track the performance of the SP Pharmaceuticals Select Industry Index , the fund employs a sampling strategy. SP Pharmaceuticals is traded on NYSEARCA Exchange in the United States.
SPDR SP generated a negative expected return over the last 90 days
Latest headline from news.google.com: Proactive Strategies - Stock Traders Daily
SPDR SP Pharmaceuticals generated-1.0 ten year return of -1.0%
This fund keeps 99.9% of its net assets in stocks
When determining whether SPDR SP Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of SPDR SP's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Spdr Sp Pharmaceuticals Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Spdr Sp Pharmaceuticals Etf:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in SPDR SP Pharmaceuticals. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
The market value of SPDR SP Pharmaceuticals is measured differently than its book value, which is the value of SPDR that is recorded on the company's balance sheet. Investors also form their own opinion of SPDR SP's value that differs from its market value or its book value, called intrinsic value, which is SPDR SP's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SPDR SP's market value can be influenced by many factors that don't directly affect SPDR SP's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SPDR SP's value and its price as these two are different measures arrived at by different means. Investors typically determine if SPDR SP is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SPDR SP's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.